CDC advisers to consider coronavirus booster shots for immunocompromised patients

A federal advisory panel is expected next week to consider whether health-care workers should be allowed to give additional coronavirus shots to patients with fragile immune systems, even as top U.S. health officials have said an additional dose of vaccine is not widely needed. The prospect of booster shots emerged last week as the maker of a two-dose coronavirus vaccine, Pfizer-BioNTech, announced it would seek regulatory approval for a third inoculation amid rising global concern about the highly transmissible delta variant.